M&D Healthcare Limited - Period Ending 2017-03-31

M&D Healthcare Limited - Period Ending 2017-03-31


M&D Healthcare Limited 07149076 false 2016-04-01 2017-03-31 2017-03-31 The principal activity of the company is Dental Practise Digita Accounts Production Advanced 6.20.8420.1 Software true 07149076 2016-04-01 2017-03-31 07149076 2017-03-31 07149076 core:RetainedEarningsAccumulatedLosses 2017-03-31 07149076 core:ShareCapital 2017-03-31 07149076 core:CurrentFinancialInstruments 2017-03-31 07149076 core:CurrentFinancialInstruments core:WithinOneYear 2017-03-31 07149076 core:Non-currentFinancialInstruments 2017-03-31 07149076 core:Non-currentFinancialInstruments core:AfterOneYear 2017-03-31 07149076 core:Goodwill 2017-03-31 07149076 core:FurnitureFittingsToolsEquipment 2017-03-31 07149076 core:LandBuildings 2017-03-31 07149076 core:OtherPropertyPlantEquipment 2017-03-31 07149076 bus:SmallEntities 2016-04-01 2017-03-31 07149076 bus:AuditExemptWithAccountantsReport 2016-04-01 2017-03-31 07149076 bus:FullAccounts 2016-04-01 2017-03-31 07149076 bus:RegisteredOffice 2016-04-01 2017-03-31 07149076 bus:Director1 2016-04-01 2017-03-31 07149076 bus:Director2 2016-04-01 2017-03-31 07149076 bus:PrivateLimitedCompanyLtd 2016-04-01 2017-03-31 07149076 core:Goodwill 2016-04-01 2017-03-31 07149076 core:ComputerEquipment 2016-04-01 2017-03-31 07149076 core:FurnitureFittingsToolsEquipment 2016-04-01 2017-03-31 07149076 core:LandBuildings 2016-04-01 2017-03-31 07149076 core:LeaseholdImprovements 2016-04-01 2017-03-31 07149076 core:OtherPropertyPlantEquipment 2016-04-01 2017-03-31 07149076 core:PlantMachinery 2016-04-01 2017-03-31 07149076 countries:AllCountries 2016-04-01 2017-03-31 07149076 2016-03-31 07149076 core:Goodwill 2016-03-31 07149076 core:FurnitureFittingsToolsEquipment 2016-03-31 07149076 core:LandBuildings 2016-03-31 07149076 core:OtherPropertyPlantEquipment 2016-03-31 07149076 2015-04-01 2016-03-31 07149076 2016-03-31 07149076 core:RetainedEarningsAccumulatedLosses 2016-03-31 07149076 core:ShareCapital 2016-03-31 07149076 core:CurrentFinancialInstruments 2016-03-31 07149076 core:CurrentFinancialInstruments core:WithinOneYear 2016-03-31 07149076 core:Non-currentFinancialInstruments 2016-03-31 07149076 core:Non-currentFinancialInstruments core:AfterOneYear 2016-03-31 07149076 core:Goodwill 2016-03-31 07149076 core:FurnitureFittingsToolsEquipment 2016-03-31 07149076 core:LandBuildings 2016-03-31 07149076 core:OtherPropertyPlantEquipment 2016-03-31 iso4217:GBP xbrli:pure

Registration number: 07149076

M&D Healthcare Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2017

image-name

DKP Accountants Sussex Limited

 

M&D Healthcare Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

4 to 8

 

M&D Healthcare Limited

Company Information

Directors

Dr K Dhanjal

Mr J Makdissi

Registered office

Cortlandt
George Street
Hailsham
East Sussex
BN27 1AE

Accountants

DKP Accountants Sussex Limited
Chartered Certified Accountants
Suite 10 Cortlandt
George Street
Hailsham
East Sussex
BN27 1AE

 

M&D Healthcare Limited

(Registration number: 07149076)
Balance Sheet as at 31 March 2017

Note

2017
£

2016
£

Fixed assets

 

Intangible assets

4

649,843

332,000

Tangible assets

5

158,200

119,224

 

808,043

451,224

Current assets

 

Debtors

6

332,747

324,511

Cash at bank and in hand

 

84,333

19,863

 

417,080

344,374

Creditors: Amounts falling due within one year

7

(155,097)

(114,618)

Net current assets

 

261,983

229,756

Total assets less current liabilities

 

1,070,026

680,980

Creditors: Amounts falling due after more than one year

7

(552,625)

(280,044)

Net assets

 

517,401

400,936

Capital and reserves

 

Called up share capital

2

2

Profit and loss account

517,399

400,934

Total equity

 

517,401

400,936

For the financial year ending 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

M&D Healthcare Limited

(Registration number: 07149076)
Balance Sheet as at 31 March 2017

Approved and authorised by the Board on 19 December 2017 and signed on its behalf by:
 

.........................................

Dr K Dhanjal

Director

.........................................

Mr J Makdissi

Director

 

M&D Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

1

General information

The company is a private company limited by share capital incorporated in England and Wales.

The address of its registered office is:
Cortlandt
George Street
Hailsham
East Sussex
BN27 1AE
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Short Leasehold

10% Straight line

Plant and Machinery

25% Straight line

Fixtures and furniture

25% Straight line

Computer Equipment

25% Straight line

 

M&D Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Over 5 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

M&D Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 25 (2016 - 23).

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 April 2016

475,000

475,000

Additions acquired separately

317,843

317,843

At 31 March 2017

792,843

792,843

Amortisation

At 1 April 2016

143,000

143,000

At 31 March 2017

143,000

143,000

Carrying amount

At 31 March 2017

649,843

649,843

At 31 March 2016

332,000

332,000

The aggregate amount of research and development expenditure recognised as an expense during the period is £Nil (2016 - £Nil).
 

 

M&D Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

5

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other property, plant and equipment
 £

Total
£

Cost or valuation

At 1 April 2016

87,827

123,314

115,767

326,908

Additions

-

10,966

75,760

86,726

At 31 March 2017

87,827

134,280

191,527

413,634

Depreciation

At 1 April 2016

52,696

57,860

97,128

207,684

Charge for the year

8,783

21,217

17,750

47,750

At 31 March 2017

61,479

79,077

114,878

255,434

Carrying amount

At 31 March 2017

26,348

55,203

76,649

158,200

At 31 March 2016

35,131

65,454

18,639

119,224

Included within the net book value of land and buildings above is £Nil (2016 - £Nil) in respect of freehold land and buildings and £26,348 (2016 - £35,130) in respect of short leasehold land and buildings.
 

6

Debtors

2017
£

2016
£

Trade debtors

137,534

129,448

Other debtors

195,213

195,063

Total current trade and other debtors

332,747

324,511

 

M&D Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

7

Creditors

Note

2017
£

2016
£

Due within one year

 

Bank loans and overdrafts

8

89,820

45,254

Trade creditors

 

34,864

20,400

Amounts owed to group undertakings and undertakings in which the company has a participating interest

3,997

29,999

Taxation and social security

 

6,613

5,965

Other creditors

 

19,803

13,000

 

155,097

114,618

Due after one year

 

Loans and borrowings

8

552,625

280,044

8

Loans and borrowings

2017
£

2016
£

Non-current loans and borrowings

Bank borrowings

552,625

280,044

2017
£

2016
£

Current loans and borrowings

Bank borrowings

89,820

45,254

9

Transition to FRS 102

These financial statements for the year ended 31 March 2017 are the first financial statements of M & D Healthcare Limited prepared in accordance with FRS 102, The financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 April 2015. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.